Literature DB >> 850315

Hormones in renal cancer.

G Sufrin, E A Mirand, R H Moore, T M Chu, G P Murphy.   

Abstract

Plasma renin, erythropoietin and chorionic gonadotropin levels were evaluated in 57 patients with renal adenocarcinoma. Renin elevation, found in 37 per cent, was unrelated to blood pressure levels but was associated with high grade, high stage lesions of mixed histologic cell type and predicted a poor prognosis. Erythropoietin was raised in 63 per cent of patients and was more sensitive than renin in indicating the presence of renal adenocarcinoma. However, it was less specific and did not correlate directly with tumor grade, stage, histologic type, prognosis or hematocrit and hemoglobin levels. None of the patients had elevated chorionic gonadotropin levels. Therefore, we believe that renin and erythropoietin determinations may be of value as biochemical tumor markers in renal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850315     DOI: 10.1016/s0022-5347(17)58490-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Immunohistochemical localization of renin in renal tumors.

Authors:  T Tomita; A Poisner; T Inagami
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

Review 2.  Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.

Authors:  M Hegemann; N Kroeger; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2018-02-10       Impact factor: 4.226

3.  Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.

Authors:  Ganesh S Palapattu; Blaine Kristo; Jacob Rajfer
Journal:  Rev Urol       Date:  2002

4.  Perioperative Considerations in Metastatic Renal Cell Carcinoma.

Authors:  Kate Flavin; Nikhil Vasdev; Jim Ashead; Tim Lane; Damian Hanbury; Paul Nathan; Shanmugasundaram Gowrie-Mohan
Journal:  Rev Urol       Date:  2016

5.  Role of endogenous prostaglandin E2 in erythropoietin production and dome formation by human renal carcinoma cells in culture.

Authors:  M Hagiwara; D B McNamara; I L Chen; J W Fisher
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Prevalence of paraneoplastic erythropoietin production by renal cell carcinomas.

Authors:  A J Gross; M Wolff; J Fandrey; W D Miersch; K P Dieckmann; W Jelkmann
Journal:  Clin Investig       Date:  1994-05

7.  Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma.

Authors:  Maria Stenman; Anna Laurell; Magnus Lindskog
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

8.  Successful treatment of erythropoietin-producing advanced renal cell carcinoma after targeted therapy using sunitinib: Case report and review of the literature.

Authors:  Kosuke Ueda; Shigetaka Suekane; Katsuaki Chikui; Makoto Nakiri; Fukuko Moriya; Tokumasa Hayashi; Jiro Miyajima; Kei Matsuoka
Journal:  Mol Clin Oncol       Date:  2012-08-03

9.  Serum beta 2 microglobulin levels in patients with renal cell carcinoma.

Authors:  C Selli; F Cozzolino; M Carini; R Lenzi; D Vercelli
Journal:  Urol Res       Date:  1984

10.  An investigation of cellular components released from human renal cancer and foetal kidney xenografts in nude mice (nu/nu) by cross-immunization of hairy littermate relatives.

Authors:  P N Matthews; J Hermon-Taylor; A G Grant
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.